查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1607018

腫瘤學和免疫學領域的流式細胞技術市場：按類型、技術、產品和服務、最終用戶分類 - 全球預測 2025-2030

Flow Cytometry in Oncology & Immunology Market by Type (Immunology, Oncology), Technology (Bead-based Flow Cytometry, Cell-based Flow Cytometry), Product & Service, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

腫瘤學和免疫學領域的流式細胞技術市場2023年估值為11億美元，預計2024年將達到11.8億美元，複合年成長率為9.33%，到2030年將達到20億美元。美元百萬。

流式細胞技術是一種強大的分析技術，廣泛應用於腫瘤學和免疫學中，用於測量穿過雷射光束的細胞和顆粒的物理和化學特性。這些領域對流式細胞技術的需求突出是因為它能夠快速對異質細胞群的表現型和功能進行多參數分析，有助於疾病診斷、預後和監測治療反應。應用包括免疫表現型分析、細胞分選、癌症生物標記檢測和細胞週期狀態測定。最終用途廣泛，包括臨床實驗室、學術研究機構、製藥公司和診斷中心。市場成長主要是由於癌症和免疫系統疾病的盛行率不斷上升、流式細胞技術技術的進步提高了分析精度並縮短了分析時間，以及受日益採用的影響，動態和藥物標靶識別等新型應用的流式細胞技術。新的商機在於整合人工智慧進行資料分析，可以提高流式細胞技術結果的速度和準確性。建議包括利用技術升級、為小型實驗室開發具有成本效益的系統，以及隨著醫療基礎設施的不斷發展擴展到開拓的市場。然而，設備和試劑的高成本、對熟練技術人員的需求以及監管限制等限制對市場滲透構成了挑戰。實驗室之間的標準化以確保資料可比性也是研究人員和臨床醫生面臨的挑戰。創新和研究的最佳領域包括開發用於照護現場的易於使用的攜帶式流式細胞技術系統以及用於提高特異性和靈敏度的新型螢光染料。該市場的特點是充滿活力和競爭格局，領先公司投資研發以推動進步並獲得競爭優勢。持續專注於降低成本、提高易用性和擴展應用對於維持市場成長至關重要。

主要市場統計
基準年[2023] 11億美元
預計年份 [2024] 11.8億美元
預測年份 [2030] 20.6億美元
複合年成長率（%） 9.33%

市場動態：針對腫瘤學和免疫學快速發展的流式細胞技術市場揭示的關鍵市場洞察

腫瘤學和免疫學領域的流式細胞技術市場正在因供需的動態相互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 癌症和免疫疾病的發生率上升
    • 個人化治療方法的不斷發展
    • 免疫學和免疫腫瘤學研究中公私舉措的激增
  • 市場限制因素
    • 設備和試劑高成本
  • 市場機會
    • 將多組體學方法整合到腫瘤學和免疫學的流式細胞技術中
    • 流式細胞技術技術的小型化與進步
  • 市場挑戰
    • 監管和合規問題以及識別和表徵稀有細胞的技術難度

波特的五力：腫瘤學與免疫學流式細胞技術市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解腫瘤學和免疫學市場流式細胞技術的外部影響

外部宏觀環境因素在塑造腫瘤學和免疫學市場流式細胞技術的性能動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解腫瘤學和免疫學流式細胞技術市場的競爭格局

對腫瘤學和免疫學市場中流式細胞技術的詳細市場佔有率分析提供了對供應商績效的全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來發現自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

腫瘤學與免疫學市場 FPNV 定位矩陣流式細胞技術供應商的績效評估

FPNV定位矩陣是評估腫瘤/免疫學流式細胞技術市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了腫瘤學和免疫學市場流式細胞技術的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對腫瘤學和免疫學市場中的流式細胞技術進行策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 癌症和免疫疾病的發生率增加
      • 個人化治療方法的開發進展
      • 免疫學和免疫腫瘤學研究領域公私合營的激增
    • 抑制因素
      • 設備和試劑成本高
    • 機會
      • 將多組體學方法整合到腫瘤學和免疫學流式細胞技術中
      • 流式細胞技術技術的小型化與進步
    • 任務
      • 監管和合規問題以及識別和表徵稀有細胞的技術挑戰相結合
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章腫瘤學和免疫學中的流式細胞技術市場：按類型

  • 免疫學
  • 腫瘤學

第7章腫瘤學與免疫學的流式細胞技術市場：依技術分類

  • 以微珠為基礎的流式細胞技術
  • 基於細胞的流式細胞技術

第8章腫瘤學和免疫學的流式細胞技術市場：按產品和服務分類

  • 配件
  • 流式細胞技術設備
    • 細胞分析儀
    • 細胞分選裝置
  • 裝置
  • 試劑/耗材
  • 服務
  • 軟體

第9章腫瘤學和免疫學中的流式細胞技術市場：按最終用戶分類

  • 學術研究所
  • 合約調查機構
  • 醫院、診斷實驗室
  • 製藥和生物技術公司

第10章美洲腫瘤學和免疫學的流式細胞技術市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區腫瘤學與免疫學流式細胞技術市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲腫瘤學和免疫學流式細胞技術市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Agilent Technologies, Inc.
  • Apogee Flow Systems Ltd.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Cytek Biosciences, Inc.
  • Enzo Life Sciences, Inc.
  • General Electric Company
  • GenScript Biotech Corporation
  • Merck KGaA
  • Miltenyi Biotec BV & CO. KG
  • Nanocellect Biomedical, Inc.
  • Novozymes A/S
  • On-Chip Biotechnologies Co., Ltd.
  • RareCyte, Inc.
  • Sartorius AG
  • Sony Biotechnology Inc.
  • Stratedigm, Inc.
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.
  • Union Biometrica, Inc.
Product Code: MRR-2E76C3E47FBA

The Flow Cytometry in Oncology & Immunology Market was valued at USD 1.10 billion in 2023, expected to reach USD 1.18 billion in 2024, and is projected to grow at a CAGR of 9.33%, to USD 2.06 billion by 2030.

Flow cytometry is a powerful analytical technology extensively used in oncology and immunology for measuring the physical and chemical characteristics of cells or particles as they pass through a laser beam. The necessity of flow cytometry in these fields is underscored by its capability for rapid multiparametric analysis of the phenotypes and functions of heterogeneous cell populations, aiding in disease diagnosis, prognosis, and monitoring of therapeutic responses. Applications include immunophenotyping, cell sorting, cancer biomarker detection, and determining cell cycle status. The end-use scope spans clinical laboratories, academic research institutions, pharmaceutical companies, and diagnostic centers. The market growth is primarily influenced by the increasing prevalence of cancers and immune system disorders, advancements in flow cytometry technologies leading to enhanced accuracy and reduced time of analysis, and the expanding adoption of flow cytometry in novel applications like pharmacodynamics and drug target identification. Emerging opportunities lie in the integration of artificial intelligence for data analysis, which can enhance the speed and accuracy of flow cytometry results. Recommendations include capitalizing on technological upgrades, developing cost-effective systems for smaller labs, and expanding into untapped markets with growing healthcare infrastructure. However, limitations such as high costs of instruments and reagents, the requirement for skilled technicians, and regulatory constraints pose challenges to market proliferation. Standardization across labs to ensure data comparability is another challenge facing researchers and clinicians. The best areas for innovation and research include the development of user-friendly, portable flow cytometry systems for point-of-care diagnostics, and novel fluorochromes to improve specificity and sensitivity. The market is characterized by a dynamic and competitive landscape, with major players investing in R&D to drive advancements and gain competitive advantage. Continued focus on cost reduction, enhanced usability, and broadening applications will be pivotal for sustaining market growth.

KEY MARKET STATISTICS
Base Year [2023] USD 1.10 billion
Estimated Year [2024] USD 1.18 billion
Forecast Year [2030] USD 2.06 billion
CAGR (%) 9.33%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Flow Cytometry in Oncology & Immunology Market

The Flow Cytometry in Oncology & Immunology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising Incidence of cancer and immunological disorders
    • Growing development of personalized treatment approaches
    • Surging public-private initiatives in the field of immunology and immune-oncology research
  • Market Restraints
    • High Cost of equipment and reagents
  • Market Opportunities
    • Integration with multi-omics approaches in flow cytometry for oncology & immunology
    • Miniaturization and advancements in flow cytometry technology
  • Market Challenges
    • Regulatory and compliance issues coupled with technically challenging for identifying and characterizing rare cell

Porter's Five Forces: A Strategic Tool for Navigating the Flow Cytometry in Oncology & Immunology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Flow Cytometry in Oncology & Immunology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Flow Cytometry in Oncology & Immunology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Flow Cytometry in Oncology & Immunology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Flow Cytometry in Oncology & Immunology Market

A detailed market share analysis in the Flow Cytometry in Oncology & Immunology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Flow Cytometry in Oncology & Immunology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Flow Cytometry in Oncology & Immunology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Flow Cytometry in Oncology & Immunology Market

A strategic analysis of the Flow Cytometry in Oncology & Immunology Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Flow Cytometry in Oncology & Immunology Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Apogee Flow Systems Ltd., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, Cytek Biosciences, Inc., Enzo Life Sciences, Inc., General Electric Company, GenScript Biotech Corporation, Merck KGaA, Miltenyi Biotec B.V. & CO. KG, Nanocellect Biomedical, Inc., Novozymes A/S, On-Chip Biotechnologies Co., Ltd., RareCyte, Inc., Sartorius AG, Sony Biotechnology Inc., Stratedigm, Inc., Sysmex Corporation, Thermo Fisher Scientific, Inc., and Union Biometrica, Inc..

Market Segmentation & Coverage

This research report categorizes the Flow Cytometry in Oncology & Immunology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Immunology and Oncology.
  • Based on Technology, market is studied across Bead-based Flow Cytometry and Cell-based Flow Cytometry.
  • Based on Product & Service, market is studied across Accessories, Flow Cytometry Instruments, Instruments, Reagents & Consumables, Services, and Software. The Flow Cytometry Instruments is further studied across Cell Analyzers and Cell Sorters.
  • Based on End User, market is studied across Academic Research Institutes, Contract Research Organizations, Hospitals, Diagnostic Laboratories, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising Incidence of cancer and immunological disorders
      • 5.1.1.2. Growing development of personalized treatment approaches
      • 5.1.1.3. Surging public-private initiatives in the field of immunology and immune-oncology research
    • 5.1.2. Restraints
      • 5.1.2.1. High Cost of equipment and reagents
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration with multi-omics approaches in flow cytometry for oncology & immunology
      • 5.1.3.2. Miniaturization and advancements in flow cytometry technology
    • 5.1.4. Challenges
      • 5.1.4.1. Regulatory and compliance issues coupled with technically challenging for identifying and characterizing rare cell
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Flow Cytometry in Oncology & Immunology Market, by Type

  • 6.1. Introduction
  • 6.2. Immunology
  • 6.3. Oncology

7. Flow Cytometry in Oncology & Immunology Market, by Technology

  • 7.1. Introduction
  • 7.2. Bead-based Flow Cytometry
  • 7.3. Cell-based Flow Cytometry

8. Flow Cytometry in Oncology & Immunology Market, by Product & Service

  • 8.1. Introduction
  • 8.2. Accessories
  • 8.3. Flow Cytometry Instruments
    • 8.3.1. Cell Analyzers
    • 8.3.2. Cell Sorters
  • 8.4. Instruments
  • 8.5. Reagents & Consumables
  • 8.6. Services
  • 8.7. Software

9. Flow Cytometry in Oncology & Immunology Market, by End User

  • 9.1. Introduction
  • 9.2. Academic Research Institutes
  • 9.3. Contract Research Organizations
  • 9.4. Hospitals, Diagnostic Laboratories
  • 9.5. Pharmaceutical & Biotechnology Companies

10. Americas Flow Cytometry in Oncology & Immunology Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Flow Cytometry in Oncology & Immunology Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Flow Cytometry in Oncology & Immunology Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Apogee Flow Systems Ltd.
  • 3. Becton, Dickinson and Company
  • 4. Bio-Rad Laboratories, Inc.
  • 5. bioMerieux SA
  • 6. Cytek Biosciences, Inc.
  • 7. Enzo Life Sciences, Inc.
  • 8. General Electric Company
  • 9. GenScript Biotech Corporation
  • 10. Merck KGaA
  • 11. Miltenyi Biotec B.V. & CO. KG
  • 12. Nanocellect Biomedical, Inc.
  • 13. Novozymes A/S
  • 14. On-Chip Biotechnologies Co., Ltd.
  • 15. RareCyte, Inc.
  • 16. Sartorius AG
  • 17. Sony Biotechnology Inc.
  • 18. Stratedigm, Inc.
  • 19. Sysmex Corporation
  • 20. Thermo Fisher Scientific, Inc.
  • 21. Union Biometrica, Inc.

LIST OF FIGURES

  • FIGURE 1. FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET DYNAMICS
  • TABLE 7. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY BEAD-BASED FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL-BASED FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL SORTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY HOSPITALS, DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLOW CYTOMETRY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 237. FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 238. FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET, FPNV POSITIONING MATRIX, 2023